Seed Companies in Cambridge

Carbon13 is the venture builder for the climate-emergency

Signaloid is a cloud-based computing platform.

PharmEnable has developed a rapid and cost effective way to identify better chemical starting points to drive the discovery.

To give businesses and markets the data they need to invest in positive outcomes for nature.

Opto Biosystems develops healthcare tech linking cancer neuroscience with bioelectronics for new treatments.

TR Global Events is a full-service events company that provides local, national & global event & DMC services.

Creators of Financial Crime Vaccines

Revolutionizing neurology diagnostics and drug discovery with Artificial Intelligence.

An intelligent information management platform, designed to increase productivity by reducing time finding, organising and processing data.

Kodiaq Technologies develops metal-free electrolytes for long-duration energy storage in flow batteries.

HutanBio is a biotechnology firm that delivers an HBx bio-oil.

AllFocal Optics revolutionizes display technology through groundbreaking nanophotonic solutions.

Coherence develops healthcare tech linking cancer neuroscience with neurotechnology for new treatments.

Molyon designs next-generation high-energy-density batteries engineered for weight-critical applications.

Decent Energy integrates and optimises small scale smart energy assets to minimise the cost and carbon intensity of the energy

Shuffle Energy (previously Komodo Energy) is a energy flexibility platform focussed specialised on thermal assets.

Charco Neurotech is a medical technology company that develops non-invasive wearable devices.

PeroCycle is an industrial decarbonization company that enables closed-loop carbon recycling in the production of steel.

Biiah is a B2B2C music health platform empowering adults to improve their mental, physical, and social health through music-making.

Wearables Health AI - Test, Apps and eHealth

Clock Bio operates as a biotech company.

Bloomsbury Genetic Therapies develops curative treatments for rare neurological and metabolic diseases using gene therapy technologies.

Revolutionising neurology diagnostics and drug discovery with the power of Artificial Intelligence.

Epitopea is a transatlantic cancer immunotherapeutics company.

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.